Eighteen percent of newborns worldwide die of neonatal sepsis, and this is accompanied by high use of last-line antibiotics to overcome resistant infections.
- Submits Clinical Trial Application for potentially life-saving therapy for pediatric patients with urea cycle disorders, setting the stage for patient enrollment in H2 2022 - OBERDORF NW, Switzerland